State Street Corp Esperion Therapeutics, Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,548,248 shares of ESPR stock, worth $5.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,548,248
Previous 4,504,234 0.98%
Holding current value
$5.32 Million
Previous $9.91 Million 33.91%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$1.44 - $2.34 $63,380 - $102,992
44,014 Added 0.98%
4,548,248 $6.55 Million
Q4 2024

Feb 14, 2025
BUY
$1.61 - $3.83 $1.05 Million - $2.49 Million
649,920 Added 16.86%
4,504,234 $9.91 Million
Q3 2024

Nov 14, 2024
BUY
$1.61 - $2.73 $160,681 - $272,459
99,802 Added 2.66%
3,854,314 $6.36 Million
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $5.89 Million - $10.4 Million
3,203,263 Added 581.09%
3,754,512 $8.34 Million
Q1 2024

May 15, 2024
BUY
$2.02 - $3.02 $338,350 - $505,850
167,500 Added 43.65%
551,249 $1.48 Million
Q4 2023

Feb 14, 2024
BUY
$0.73 - $3.08 $59,349 - $250,404
81,300 Added 26.88%
383,749 $1.15 Million
Q2 2023

Aug 14, 2023
SELL
$1.2 - $1.76 $1.92 Million - $2.82 Million
-1,600,965 Reduced 84.11%
302,449 $420,000
Q1 2023

May 15, 2023
BUY
$1.46 - $7.3 $217,693 - $1.09 Million
149,105 Added 8.5%
1,903,414 $3.03 Million
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $1.13 Million - $1.88 Million
221,161 Added 14.43%
1,754,309 $10.9 Million
Q3 2022

Nov 15, 2022
BUY
$5.45 - $8.13 $1.57 Million - $2.35 Million
288,609 Added 23.19%
1,533,148 $10.3 Million
Q2 2022

Aug 15, 2022
BUY
$4.77 - $6.67 $1.57 Million - $2.19 Million
328,101 Added 35.8%
1,244,539 $7.92 Million
Q1 2022

May 16, 2022
SELL
$3.34 - $5.56 $433,996 - $722,460
-129,939 Reduced 12.42%
916,438 $4.25 Million
Q4 2021

Feb 14, 2022
BUY
$4.81 - $11.92 $2.26 Million - $5.59 Million
469,096 Added 81.26%
1,046,377 $5.23 Million
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $19 Million - $35.8 Million
-1,674,913 Reduced 74.37%
577,281 $6.96 Million
Q2 2021

Aug 16, 2021
BUY
$19.4 - $28.71 $2.59 Million - $3.84 Million
133,748 Added 6.31%
2,252,194 $47.6 Million
Q1 2021

May 17, 2021
SELL
$25.12 - $36.89 $10.2 Million - $14.9 Million
-404,098 Reduced 16.02%
2,118,446 $59.4 Million
Q4 2020

Feb 16, 2021
BUY
$24.2 - $35.76 $17.4 Million - $25.7 Million
719,794 Added 39.93%
2,522,544 $65.6 Million
Q3 2020

Nov 10, 2020
BUY
$31.18 - $52.71 $1.72 Million - $2.9 Million
55,054 Added 3.15%
1,802,750 $67 Million
Q2 2020

Aug 14, 2020
BUY
$30.04 - $51.31 $19.3 Million - $32.9 Million
641,079 Added 57.93%
1,747,696 $89.7 Million
Q1 2020

May 11, 2020
BUY
$27.44 - $73.84 $30.4 Million - $81.7 Million
1,106,617 New
1,106,617 $34.9 Million

Others Institutions Holding ESPR

# of Institutions
200
Shares Held
119M
Call Options Held
171K
Put Options Held
679K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $77.9M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email